Abingworth Management, the international life sciences venture capital group, has appointed Michael Bigham as a director of Abingworth Management and as a partner of Abingworth Bioventures III. He will be based at the company’s offices in Palo Alto, California. Abingworth is headquartered in London, UK and has a third office in Cambridge, UK.
Bigham is currently vice chairman of Corixa Corporation, a public biotechnology company focused on the treatment and prevention of autoimmune diseases, cancer and infectious diseases. He was president and chief executive of Coulter Pharmaceuticals from July 1996 until it merged into Corixa in December 2000. Prior to this, he was an early employee at Gilead Sciences where he spent eight years serving in various capacities, including executive vice president of operations and CFO.